Effisayil 2 Archives - Medical Conferences

High-dose subcutaneous spesolimab prevents GPP flares up to week 48

Presented By

Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany

Trial

Phase 2, Effisayil 2

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 12:23

Presented By

Prof. Bruce Strober, Yale University School of Medicine, CT, USA

Trial

Effisayil 2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:32

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:04